Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > NEXT WEEK
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Marcel7on Nov 08, 2015 11:21am
80 Views
Post# 24271146

RE:RE:RE:RE:NEXT WEEK

RE:RE:RE:RE:NEXT WEEK
argentia77 wrote: If I'm interpreting this correctly it looks like shorters stand to lose a minimum of $450,500 in the next few weeks for every $1 increase in the SP above the average strike price as they are forced to cover their bets. 


Shares Short (as of Nov 2, 2015)3: 450.50k
Short Ratio (as of Nov 2, 2015)3: 0.30
Short % of Float (as of Nov 2, 2015)3: N/A
Shares Short (prior month)3: 208.41k


Thank you for posting this! What is your source if you don't mind my asking?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities